Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.
The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...
SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of ...
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...
Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute. The lab enables genomic testing results to be more quickly integrated ...
BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY ® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...
(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today announced the ...
Every year, 20,000 genetic tests are sent to laboratories in the UK, US, Germany, Spain and Finland - senators want to bring that testing back to Ireland ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results